These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 18485459

  • 1. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment.
    Becker F, Siemer S, Tzavaras A, Suttmann H, Stoeckle M.
    Urology; 2008 Aug; 72(2):349-53. PubMed ID: 18485459
    [Abstract] [Full Text] [Related]

  • 2. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 3. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML.
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [Abstract] [Full Text] [Related]

  • 4. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M.
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [Abstract] [Full Text] [Related]

  • 6. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [Abstract] [Full Text] [Related]

  • 7. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M.
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [Abstract] [Full Text] [Related]

  • 8. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T, Kondo T, Izuka J, Kobayashi H, Tomita E, Hashimoto Y, Tanabe K.
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M.
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T, Wunderlich H, Patard JJ, Kleid MD, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ.
    BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
    [Abstract] [Full Text] [Related]

  • 11. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
    Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ.
    J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M, Hupertan V, Comperat E, Renard-Penna R, Vaessen C, Conort P, Bitker MO, Chartier-Kastler E, Richard F, Rouprêt M.
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [Abstract] [Full Text] [Related]

  • 13. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML, Amling CL, Bryant SC, Zincke H.
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA.
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 16. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
    Amano H, Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Shimada K, Nakazawa H, Ito F, Tanabe K.
    Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A, Cozzoli A, Simeone C, Zani D, Zanotelli T, Portesi E, Cosciani Cunico S.
    BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
    [Abstract] [Full Text] [Related]

  • 18. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A, Serni S, Giubilei G, Lanzi F, Vittori G, Lapini A, Carini M.
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [Abstract] [Full Text] [Related]

  • 19. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V, Novara G, Galfano A, Novella G, Schiavone D, Artibani W.
    Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
    [Abstract] [Full Text] [Related]

  • 20. Outcomes following partial nephrectomy by tumor size.
    Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC.
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.